The role of Toll-like receptors in pathogenesis of certain dermatoses

Sorokina E.V.; Masiukova S.A.

doi:https://doi.org/

References:

Akhmatova N.K., Kiselevskii M.V. Vrozhdennyi immunitet protivoopukholevyi i protivoinfektsionnyi. M 2008.
Simbirtsev A.S. Toll-belki: spetsificheskie retseptory nespetsificheskogo immuniteta. Immunologiya 2005; 6: 368-376.
Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 18: 819-826.
Baker B.S., Ovigne J.M., Powles A.V. et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: Modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003; 148: 670-679.
Nardelli D.T., Callister S.M., Schell R.F. Lyme arthritis. Current consepts and change in paradigm. Clin Vaccine Immunol 2008; 15: 1: 21-34.
McInturff J.E., Modlin R.L., Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125: 1-8.
Charles J., Chaperot L., Salameire D. et al. Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer. Eur J Dermatol 2010; 20: 1: 16-23.
Kawai K. Expression of functional Toll-like receptors on cultured human epidermal keratinocytes. J Invest Dermatol 2003; 121: 217.
Miller L.S. Toll-like receptors in skin. Adv Dermatol 2008; 24: 71-87.
Pivarcsi A., Bodai L., Rethi B. et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721-730.
Lai Y., Gallo R.L. Toll-like receptors in skin infectious and inflammatory diseases. Infect Dis Drug Targets 2008; 8: 3: 144-155.
Pivarcsi A., Nagy I., Kemeny L. Innate immunity in the skin: how keratinocytes fight against pathogens. Curr Immunol Rev 2005; 1: 29-42.
Kollisch G., Kalali B.N., Voelcker V. et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005; 114: 4: 531-541.
Harder J., Bartels J., Christophers E. et al. A peptide antibiotic from human skin. Nature 1997; 387: 861.
Matsubara M., Harada D., Manabe H. et al. Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. Clin Exp Immunol 2004; 566: 195-200.
Schauber J., Gallo R.L. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008; 122: 2: 261-266.
Blankenvoorde M.F., van't Hof W., Walgreen-Weterings E. et al. Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol Chem 1998; 379: 1371-1375.
Glaser R., Harder J., Lange H. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005; 6: 57-64.
Morioka Y., Yamasaki K., Leung D., Gallo R.L. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. J Immunol 2008; 181: 6: 3915-3922.
Ahmad-Nejad P., Mrabet-Dahbi S., Breuer K. et al. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113: 3: 565-567.
Lorenz E., Mira J.P., Cornish K.L. et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 11: 6398-6401.
Weidinger S., Novak N., Klopp N. et al. Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema. J Allergy Clin Immunol 2006; 118: 1: 277-279.
Hasannejad H., Takahashi R., Kimishima M. et al. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2007; 120: 1: 69-75.
Nomura I., Goleva E., Howell M.D. et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003; 171: 3262-3269.
Ong P.Y., Ohtake T., Brandt C. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
Birchler T., Seibl R., Buchner K. et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human Β-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 2001; 31: 3131-3137.
Carroll J.M., Crompton T., Seery J.P. et al. Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 1997; 108: 412-422.
Howell M.D., Novak N., Bieber T.et al. Interleukin-10 downregulates antimicrobial peptide expression in atopic dermatitis. J Invest Dermatol 2005; 125: 738-745.
Baroni A., Orlando M., Donnarumma G. et al. Toll-like receptor 2 (TLR2) mediates intracellular signaling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res 2006; 297: 280-288.
Kim J., Ochoa M.T., Krutzik S.R. et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 3: 1535-1541.
Salazar J.C., Pope C.D., Sellati T.J. et al. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol 2003; 171: 2660-2670.
Manzenyuk I.N., Manzenyuk O.Yu. Kleshchevye borreliozy (bolezn' Laima). Kol'tsovo 2005.
Infante-Duarte C., Horton H.F., Byrne M.C., Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000; 165: 6107-6115.
Yarilin A.A. Osnovy immunologii. M 1999.
Beelen A.J., Teunissen M.B., Kapsenberg M.L. et al. Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 2007; 7: 5: 374-381.
Kupper T.S., Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004; 4: 3: 211-222.
Henseler T., Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
Begon E., Michel L., Flageul B. et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 2007; 17: 6: 497-506.
Curry J.L., Qin J.Z., Bonish B. et al. Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 2003; 127: 178-186.
Miller L.S., Sorensen O.E., Liu P.T. et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005; 174: 10: 6137-6143.
Seung N.R., Park E.J., Kim C.W. et al. Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. J Cutan Pathol 2007; 34: 12: 903-911.
Hashimoto M., Tawaratsumida K., Kariya H. et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 2006; 177: 5: 3162-3169.
Henzler Wildman K.A., Lee D.K., Ramamoorthy A. Mechanism of lipid bilayer disruptin by the human antimicrobial peptide, LL-37. Biochemistry 2003; 42: 6545-6558.
Hollox E.J., Huffmeier U., Zeeuwen P.L. et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40: 23-25.
Lande R., Gregorio J., Facchinetti V. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-569.
Menzies B.E., Kenoyer A. Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 2006; 74: 12: 6847-6854.
Dorschner R.A., Lopez-Garcia B., Massie J. et al. Innate immune defense of the nail unit by antimicrobial peptides. J Am Acad Dermatol 2004; 50: 343-348.
Iimura M., Gallo R.L., Hase K. et al. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 2005; 174: 4901-4907.
Lopez-Garcia B., Lee P.H., Yamasaki K., Gallo R.L. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 2005; 125: 108-115.